Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 02-2015 | 11-2014 | 07-2014 | 04-2014 | 01-2014 | |
| Sales | 3 | 0 | 136 | 168 | 160 |
| Cost of Goods | 2 | N/A | 82 | 110 | 127 |
| Gross Profit | 1 | N/A | 54 | 58 | 33 |
| Operating Expenses | 454 | 363 | 580 | 486 | 117 |
| Operating Income | -453 | -363 | -526 | -428 | -84 |
| Interest Expense | 0 | 32 | 39 | 51 | 57 |
| Other Income | -6 | -4 | -3 | -14 | 39 |
| Pre-tax Income | -459 | -398 | -568 | -493 | -102 |
| Net Income Continuous | -459 | -398 | -568 | -493 | -102 |
| Net Income Discontinuous | 0 | 49 | N/A | N/A | N/A |
| Minority Interests | N/A | 2 | N/A | N/A | N/A |
| Net Income | $-459 | $-347 | $-568 | $-493 | $-102 |
| EPS Basic Total Ops | -0.27 | -0.27 | -0.55 | -0.55 | -0.27 |
| EPS Basic Continuous Ops | -0.39 | -0.46 | -0.55 | -0.55 | -0.27 |
| EPS Basic Discontinuous Ops | 0.00 | 0.06 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.27 | -0.27 | -0.55 | -0.55 | -0.27 |
| EPS Diluted Continuous Ops | -0.39 | -0.46 | -0.55 | -0.55 | -0.27 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.06 | N/A | N/A | N/A |
| EBITDA(a) | $-459 | $-367 | $-481 | $-386 | $12 |